MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now?

McKesson's (MCK) shares have gained 4.4% following its fourth-quarter fiscal 2025 earnings release on May 9. The post-earnings upside reflects growing investor confidence in McKesson's strategic execution and long- term positioning, underpinned by record full-year revenues of $359 billion and a 20% year-over-year increase in adjusted earnings per share (to $33.05). The market's positive response highlights the strength of McKesson's transformation into a more diversified healthcare service provider with a s ...